Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Loeffler

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Experimental Gerontology|April 28, 2015
Effects of antibodies to phosphorylated and non-phosphorylated tau on in vitro tau phosphorylation at Serine-199: Preliminary reportDavid A Loeffler, Lynnae M Smith, Andrea C Klaver, et al.
Biochemistry|December 30, 2014
Effects of tau domain-specific antibodies and intravenous immunoglobulin on tau aggregation and aggregate degradationJose O Esteves-Villanueva, Hanna Trzeciakiewicz, David A Loeffler, et al.
Frontiers in Aging Neuroscience|June 6, 2018
Cerebrospinal Fluid Concentration of Key Autophagy Protein Lamp2 Changes Little During Normal AgingDavid A Loeffler, Andrea C Klaver, Mary P Coffey, et al.
Journal of Neuroscience Methods|December 18, 2010
Specificity and sensitivity of the Abeta oligomer ELISAAndrea C Klaver, Lynnae M Patrias, John M Finke, et al.
Immunology Letters|August 10, 2013
Comparison of ELISA measurements of anti-Aβ concentrations and percentages of specific binding to Aβ between unfractionated intravenous immunoglobulin products and their purified anti-Aβ antibodiesAndrea C Klaver, Mary P Coffey, Lynnae M Smith, et al.
Brain Research|February 20, 2018
CSF lamp2 concentrations are decreased in female Parkinson's disease patients with LRRK2 mutationsAndrea C Klaver, Mary P Coffey, Jan O Aasly, et al.
International Immunopharmacology|May 15, 2013
Intravenous immunoglobulin products contain specific antibodies to recombinant human tau proteinLynnae M Smith, Mary P Coffey, Andrea C Klaver, et al.
Journal of Parkinson'S Disease|July 20, 2019
What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson's Disease Patients and Healthy Subjects with Parkinson's-Associated LRRK2 Mutations?David A Loeffler, Jan O Aasly, Peter A LeWitt, et al.
Translational Neurodegeneration|December 6, 2017
Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer's disease subjects: an exploratory studyAndrea C Klaver, Mary P Coffey, David A Bennett, et al.
International Immunopharmacology|October 21, 2009
Antibody concentrations to Abeta1-42 monomer and soluble oligomers in untreated and antibody-antigen-dissociated intravenous immunoglobulin preparationsAndrea C Klaver, John M Finke, Jyothi Digambaranath, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Experimental Gerontology|April 28, 2015
Effects of antibodies to phosphorylated and non-phosphorylated tau on in vitro tau phosphorylation at Serine-199: Preliminary reportDavid A Loeffler, Lynnae M Smith, Andrea C Klaver, et al.
Biochemistry|December 30, 2014
Effects of tau domain-specific antibodies and intravenous immunoglobulin on tau aggregation and aggregate degradationJose O Esteves-Villanueva, Hanna Trzeciakiewicz, David A Loeffler, et al.
Frontiers in Aging Neuroscience|June 6, 2018
Cerebrospinal Fluid Concentration of Key Autophagy Protein Lamp2 Changes Little During Normal AgingDavid A Loeffler, Andrea C Klaver, Mary P Coffey, et al.
Journal of Neuroscience Methods|December 18, 2010
Specificity and sensitivity of the Abeta oligomer ELISAAndrea C Klaver, Lynnae M Patrias, John M Finke, et al.
Immunology Letters|August 10, 2013
Comparison of ELISA measurements of anti-Aβ concentrations and percentages of specific binding to Aβ between unfractionated intravenous immunoglobulin products and their purified anti-Aβ antibodiesAndrea C Klaver, Mary P Coffey, Lynnae M Smith, et al.
Brain Research|February 20, 2018
CSF lamp2 concentrations are decreased in female Parkinson's disease patients with LRRK2 mutationsAndrea C Klaver, Mary P Coffey, Jan O Aasly, et al.
International Immunopharmacology|May 15, 2013
Intravenous immunoglobulin products contain specific antibodies to recombinant human tau proteinLynnae M Smith, Mary P Coffey, Andrea C Klaver, et al.
Journal of Parkinson'S Disease|July 20, 2019
What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson's Disease Patients and Healthy Subjects with Parkinson's-Associated LRRK2 Mutations?David A Loeffler, Jan O Aasly, Peter A LeWitt, et al.
Translational Neurodegeneration|December 6, 2017
Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer's disease subjects: an exploratory studyAndrea C Klaver, Mary P Coffey, David A Bennett, et al.
International Immunopharmacology|October 21, 2009
Antibody concentrations to Abeta1-42 monomer and soluble oligomers in untreated and antibody-antigen-dissociated intravenous immunoglobulin preparationsAndrea C Klaver, John M Finke, Jyothi Digambaranath, et al.
Pageof 5